Read more from STAT & other publishers

  1. State oversight of compounding pharmacies varies dramatically
    STAT
  2. FDA sues to stop a wayward drug compounder
    STAT
  3. Proposed legislation could heighten controversy over compounding pharmacies
    STAT
  4. Pharma whistleblower takes on India's regulators
    STAT
  5. FDA slams another Indian drug maker for serious quality problems
    STAT

 

  1. Europe Agrees: Learn the Signs of Atypical DKA in Patients Using SGLT-2s
    Diabetes In Control, 2016
  2. Addressing environmental contaminants in pediatric practice.
    Catherine Karr, Pediatr Rev, 2011
  3. AACE/ACE Position Statement On SGLT-2 Inhibitors and DKA Risk
    Diabetes In Control, 2016
  4. International travel with children: tips for physicians and families.
    Laura E Ferguson et al., Pediatr Rev, 2006
  5. FDA Tracks Fake Avastin to Foreign Supply Distributed in U.S.
    By: Kerri Wachter, Oncology Practice Digital Network, The Oncology Practice, 2012
Powered by